BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abubakar MB, Sanusi KO, Ugusman A, Mohamed W, Kamal H, Ibrahim NH, Khoo CS, Kumar J. Alzheimer’s Disease: An Update and Insights Into Pathophysiology. Front Aging Neurosci 2022;14:742408. [DOI: 10.3389/fnagi.2022.742408] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Li S, Li Y, Sun W, Qin Z, Lu Y, Song Y, Ga M, Yuan F, Liu Q. Sanwei DouKou Decoction ameliorate Alzheimer disease by increasing endogenous neural stem cells proliferation through the Wnt/β-catenin signalling pathway. J Ethnopharmacol 2023;309:116364. [PMID: 36921910 DOI: 10.1016/j.jep.2023.116364] [Reference Citation Analysis]
2 Xiao S, Zhang Y, Liu Z, Li A, Tong W, Xiong X, Nie J, Zhong N, Zhu G, Liu J, Liu Z. Alpinetin inhibits neuroinflammation and neuronal apoptosis via targeting the JAK2/STAT3 signaling pathway in spinal cord injury. CNS Neurosci Ther 2023;29:1094-108. [PMID: 36627822 DOI: 10.1111/cns.14085] [Reference Citation Analysis]
3 Ailioaie LM, Ailioaie C, Litscher G. Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine? Pharmaceutics 2023;15:916. [DOI: 10.3390/pharmaceutics15030916] [Reference Citation Analysis]
4 Shaji D, Das A, Suzuki R, Nagura Y, Sabishiro H, Kurita N. Proposal of novel ApoE4 inhibitors from the natural spice Cinnamon for the treatment of Alzheimer's disease: Ab initio molecular simulations. Biophys Chem 2023;296:106990. [PMID: 36898350 DOI: 10.1016/j.bpc.2023.106990] [Reference Citation Analysis]
5 Roy H, Srungarapati S, Gade NJ, Gummadi A, Marry Karunasree BK, Dakkumalla M, Maddiboyina B. Citicoline loaded nanoemulsion enriched with D-alpha-Tocopherol acetate and protein: Formulation and in-silico study. Journal of Drug Delivery Science and Technology 2023. [DOI: 10.1016/j.jddst.2023.104340] [Reference Citation Analysis]
6 Krunić MJ, Penjišević JZ, Suručić RV, Šegan S, Kostić-rajačić SV, Jevtić II. Structure-activity and binding orientations analysis of potent, newly synthesized, acetylcholinesterase inhibitors. Journal of Molecular Structure 2023;1276:134809. [DOI: 10.1016/j.molstruc.2022.134809] [Reference Citation Analysis]
7 Job N, Thimmakondu VS, Thirumoorthy K. In Silico Drug Design and Analysis of Dual Amyloid-Beta and Tau Protein-Aggregation Inhibitors for Alzheimer's Disease Treatment. Molecules 2023;28. [PMID: 36771052 DOI: 10.3390/molecules28031388] [Reference Citation Analysis]
8 Zhao T, Liu C, Liu L, Wang X, Liu C. Aging-accelerated differential production and aggregation of STAT3 protein in neuronal cells and neural stem cells in the male mouse spinal cord. Biogerontology 2023;24:137-48. [PMID: 36550376 DOI: 10.1007/s10522-022-10004-z] [Reference Citation Analysis]
9 Korovesis D, Rubio-Tomás T, Tavernarakis N. Oxidative Stress in Age-Related Neurodegenerative Diseases: An Overview of Recent Tools and Findings. Antioxidants (Basel) 2023;12. [PMID: 36670993 DOI: 10.3390/antiox12010131] [Reference Citation Analysis]
10 Cary G, Wiley J, Gockley J, Keegan S, Heath L, Butler R, Mangravite L, Logsdon B, Longo F, Levey A, Greenwood A, Carter G, The Emory-Sage-SGC TREAT-AD Center. Genetic and Multi-omic Risk Assessment of Alzheimer’s Disease Implicates Core Associated Biological Domains.. [DOI: 10.1101/2022.12.15.22283478] [Reference Citation Analysis]
11 Lim J, Kim S, Lee C, Park J, Yang G, Yook T. Verbenalin Reduces Amyloid-Beta Peptide Generation in Cellular and Animal Models of Alzheimer's Disease. Molecules 2022;27. [PMID: 36557811 DOI: 10.3390/molecules27248678] [Reference Citation Analysis]
12 Zeng P, Liu Y, Wang X, Ye C, Sun Y, Su H, Qiu S, Li Y, Wang Y, Wang Y, Ma J, Li M, Tian Q. Targets and mechanisms of Alpinia oxyphylla Miquel fruits in treating neurodegenerative dementia. Front Aging Neurosci 2022;14. [DOI: 10.3389/fnagi.2022.1013891] [Reference Citation Analysis]
13 Carradori S, Fantacuzzi M, Ammazzalorso A, Angeli A, De Filippis B, Galati S, Petzer A, Petzer JP, Poli G, Tuccinardi T, Agamennone M, Supuran CT. Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases? Molecules 2022;27. [PMID: 36431918 DOI: 10.3390/molecules27227816] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Mandel N, Agarwal N. Role of SUMOylation in Neurodegenerative Diseases. Cells 2022;11:3395. [DOI: 10.3390/cells11213395] [Reference Citation Analysis]
15 Tudorancea IM, Ciorpac M, Stanciu GD, Caratașu C, Săcărescu A, Ignat B, Burlui A, Rezuș E, Creangă I, Alexa-Stratulat T, Tudorancea I, Tamba BI. The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases. Biomedicines 2022;10:2492. [PMID: 36289755 DOI: 10.3390/biomedicines10102492] [Reference Citation Analysis]
16 Huynh Q, Elangovan S, Holsinger RMD. Non-Pharmacological Therapeutic Options for the Treatment of Alzheimer’s Disease. IJMS 2022;23:11037. [DOI: 10.3390/ijms231911037] [Reference Citation Analysis]
17 Hernández-Rodríguez M, Clemente CF, Macías-Pérez ME, Rodríguez-Fonseca RA, Vázquez MIN, Martínez J, Ruvalcaba RM, Rosas MM, Jiménez EM. Contribution of hyperglycemia-induced changes in microglia to Alzheimer's disease pathology. Pharmacol Rep 2022. [PMID: 36042131 DOI: 10.1007/s43440-022-00405-9] [Reference Citation Analysis]